Similar results were observed in the Chinese Glioma Genome Atlas (CGGA) dataset, where mRNA levels of RIPK1, RIPK3, and MLKL were elevated across glioma grades (Fig. S1A). This evidence concerns the gene RIPK1 and central nervous system cancer.